InsidersTradesSigma
Follow the ALTERITY THERAPEUTICS LIMITED share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Market capitalisation: €106.6m. The latest transaction was filed on 29 June 2026 (Change in Substantial Holding). Among the most active insiders: listed in Annexure A (Group Entity),(together BNY). All data is openly available.
Analysts rate ALTERITY THERAPEUTICS LIMITED Strong Buy (bullish), based on 2 analysts. Average price target: A$3.28.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
ALTERITY THERAPEUTICS LIMITED 是一家生物制药公司，专注于开发神经退行性疾病的治疗方法。该公司在 XASX 市场上市。